» Sur le Web » Clinical Trials News From Medical News Today
mardi 19 juin 2018


Clinical Trials News From Medical News Today

Latest Clinical Trials News From Medical News Today.

Les derniers articles du site :
GenoMed To Offer Free Mumps Trial
GenoMed Inc., a St. Louis, Missouri-based Next Generation Disease Management company whose business is public health™, announced today that it is offering a free clinical trial for mumps, using already existing medications. (The cost of the drugs, about $1 a day, is extra). GenoMed (...)
jeudi 20 avril 2006
Urgent Changes Needed For Authorisation Of Phase I Trials
The disastrous events of the TGN1412 trial indicate that urgent change is needed in the approval processes and regulation of phase I trials of biological agents, states an editorial in this week's issue of The Lancet.The UK Medicines and Healthcare products Regulatory Agency (MHRA) authorised (...)
lundi 17 avril 2006
Stem Cells Make "Human" Drug Trials In Animals Possible
By injecting human stem cells into laboratory mice and creating various human tissues, researchers at the Technion-Israel Institute of Technology have developed a way to conduct "human" drug trials on animals. Conducting trials on the human cell tissue carried by the mice gives scientists an (...)
lundi 17 avril 2006
Emisphere Completes Enrollment For Phase II Oral Insulin Clinical Trial
EmisphereTechnologies, Inc. (Nasdaq: EMIS) today announced it has completedenrollment of the first 120 patients in its Phase II oral insulin clinicaltrial (the "Trial"), and has received permission from regulatoryauthorities in India to expand the Trial enrollment from 120 patients to140 (...)
dimanche 16 avril 2006
Supplemental Biologics License Application For Avastin(R) With Chemotherapy In First-Line, Non-Squamous, Non-Small Cell Lung Cancer
Genentech, Inc. (NYSE: DNA) announced today that the company submitted asupplemental Biologics License Application (sBLA) with the U.S. Food andDrug Administration (FDA) for Avastin(R) (bevacizumab) in combination withplatinum-based chemotherapy for first-line treatment of advanced, (...)
dimanche 16 avril 2006
Curry Colouring And Fat Mix Could Help Diabetics
Brisbane immunologist Dr Brendan O'Sullivan hopes to put a dent in skyrocketing rates of diabetes in Australia by creating a new treatment for Type 2 diabetes.The Senior Research Officer and his team at UQ's Centre for Immunology and Cancer Research (CICR) are developing a drug that targets (...)
samedi 15 avril 2006
Second Pivotal Phase III Trial Of Alfimeprase Begins For The Treatment Of Acute Peripheral Arterial Occlusion, Bayer HealthCare And Nuvelo Inc
Bayer HealthCare (BHC) and Nuvelo Inc. (Nasdaq: NUVO) today announced that they had begun patient enrollment in a second pivotal phase III clinical trial of alfimeprase for the treatment of acute peripheral arterial occlusion (PAO). This phase III trial, known as NAPA-3 (Novel Arterial (...)
samedi 15 avril 2006
Combination Therapy Trial To Treat Relapsing-Remitting Multiple Sclerosis
Mount Sinai School of Medicine is the Clinical Coordinating Center for the first study to assess the effectiveness of combining two FDA approved medications as initial treatment for people with Relapsing Remitting Multiple Sclerosis. Sponsored by the National Institutes of Health - National (...)
samedi 15 avril 2006
Drug Company-Funded Research Often Favors Company's Medication, Study Of Antipsychotic Drug Clinical Trials Indicates
Studies funded by pharmaceutical companies usually find that the best drug is the one made by the companies sponsoring the trials, according to a study in the American Journal of Psychiatry, the ... click link for more info.
vendredi 14 avril 2006
MedImmune Begins Dosing Of Lupus Patients In Phase 1 Clinical Trial
MedImmune, Inc.(Nasdaq: MEDI) announced today that it has begun dosing lupus patients in aPhase 1 clinical trial to evaluate the safety and tolerability of MEDI-545,its monoclonal antibody (MAb) targeting interferon-alpha. The MAb is beingdeveloped for the potential treatment of patients with (...)
vendredi 14 avril 2006
Accueil     |    Plan du site     |    Espace rédacteurs     |    Se connecter
  Mis à jour le vendredi 1er juin 2018